Navigation Links
Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Date:12/17/2008

standard of care for up to five days.

The adult clinical development program for Acetavance is now complete. An analysis of data from nine placebo-controlled, single and repeated dose trials conducted in more than 1,300 adults with acute postoperative pain or fever demonstrated that intravenous acetaminophen has a hepatic safety profile comparable to placebo, with liver function test elevations reported as a treatment-emergent adverse event in 5.0% of subjects who received placebo compared to only 3.1% of subjects who received intravenous acetaminophen.

In addition, the company announced today that Study 102, a clinical trial to evaluate the pharmacokinetics of Acetavance in 75 pediatric patients, demonstrated the expected pharmacokinetic profile, generally comparable to adults, with an age-related reduction in clearance in newborns. Acetavance was well-tolerated across all age groups, ranging from newborns to adolescents. Furthermore, the company announced that it has closed patient enrollment in its last required clinical trial of Acetavance, Study 352, evaluating safety in children after one to five days of repeated doses of Acetavance up to 15 mg/kg. With the results of Study 352, which are expected in the first quarter of 2009, the planned pediatric clinical development program for Acetavance will also be complete.

"We are pleased with the successful completion of studies 304, 351, and 102," stated Ted Schroeder, President and Chief Executive Officer of Cadence. "The Acetavance New Drug Application for the treatment of acute pain and fever in both adults and children remains on track for submission during the second quarter of 2009."

Conference Call and Webcast on December 17, 2008 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)

Cadence management will host a conference call on December 17, 2008 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). Interested inv
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
2. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
3. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... , ... At Renew Man™, we have seen an increasing number of our ... the primary care physician dictates and the patient obeys. Instead, our clients are members ... issues and empowered to choose their own treatment options. , Recognizing that many men ...
(Date:9/3/2015)... ... September 03, 2015 , ... James Earl Jones will be ... In this episode, James Earl Jones will introduce a segment that discusses why it ... and how workplace wellness can be fostered in any working environment. , Employers are ...
(Date:9/3/2015)... ... September 03, 2015 , ... Fashion designer Kim (29 years old, ... most recent episode of the hit ABC series “Extreme Weight Loss” Season 5 ... her industry. She provided herself with the motivation to transform when she designed a ...
(Date:9/2/2015)... ... September 03, 2015 , ... Sara Bleich, Ph.D., associate professor ... Health and an internationally recognized scholar on obesity prevention and control, has been ... Baltimore native and 1996 graduate of Garrison Forest School, an all-girls’ independent school ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... by the Military Officers Association of America (MOAA) and Wounded Warrior Project® ... Caring For Our Own,” expert panelists will lead interactive discussions on the ...
Breaking Medicine News(10 mins):Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3
... with care as your parents and loved ones prepare for ... to keep most of familiar traditions that helped define your ... notice that things don,t quite look the same as they ... this holiday checklist from Home Instead Senior Care if you ...
... German . , Chocolate, excitement and the stress ... They are also responsible for triggering migraines in many young ... just as important as getting the right medication. However the ... today stressed that parents and young people need to be ...
... Majority Predict Increase in Consumer-directed Plan Participation , ... Nearly three-quarters of health plan executives expect the current ... than the 2001-2002 downturn, according to a survey released today ... Future: Health Plans Respond to the Financial Crisis." While few ...
... isn,t a new technology, but it,s always finding ... ads in magazines, certain time-release pharmaceuticals, and (perhaps ... , Now Sandia National Laboratories resident microencapsulation ... company to use microencapsulation technology in a novel ...
... PA, 17 December 2008 - Elsevier, world-leading publisher of ... pleased to announce that, beginning in January 2009, the ... ( JPSM ) (http://www.jpsmjournal.com) will be the official ... Medicine (AAHPM). The JPSM will continue ...
... Dec. 17 /PRNewswire/ -- Finesse Solutions, LLC, ... science process applications, announced the introduction of an autoclavable ... requires less maintenance than traditional DO sensors currently used ... "Our new TruDO Optical sensor ushers in next-generation ...
Cached Medicine News:Health News:Does Your Senior Need Help at Home? A Holiday Checklist for Anyone Caring for Seniors 2Health News:Does Your Senior Need Help at Home? A Holiday Checklist for Anyone Caring for Seniors 3Health News:Migraines: Help for a common problem in children and teenagers 2Health News:Health Plan Executives Foresee Continued Decline in Small Business Enrollment, According to CSC Survey 2Health News:Health Plan Executives Foresee Continued Decline in Small Business Enrollment, According to CSC Survey 3Health News:Sandia's microencapsulation project gives local entrepreneur warm glow 2Health News:Sandia's microencapsulation project gives local entrepreneur warm glow 3Health News:Elsevier announces new partnership between the Journal of Pain and Symptom Management and the AAHPM 2Health News:Finesse Announces TruDO Optical Autoclavable Sensors for Bioprocess Applications 2
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hcb7bz/pharmaceutical ) has ... (London, UK - November 16-18, 2015)" conference to their offering. ... including Columbia, Peru , Brazil ... Uruguay , Paraguay , ... , Chile This seminar can ...
(Date:9/2/2015)... 2, 2015  Seeger Weiss LLP is reporting that ... commence October 13, 2015. Since the ... approval program, Zimmer NexGen knee implant surpassed FDA investigation ... companies provide evidence that the product is substantially similar ... gain permissions. In 2001, Zimmer began ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/cnq7tc/medical_device ) has ... Studies: Clinical Evidence (London, UK - November 10-11, ... This course has been designed specifically for ... required for medical devices and in-vitro diagnostic products. ... and the emphasis on high quality, appropriate clinical ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in Latin America Seminar - London, UK - November 16-18, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2
... Recorders are Medical Grade VCR and VTR's ... medical environments such as ultrasound, endoscopy, radiology ... compact design and optional control via RS-232. ... features and formats. Whether it is digital ...
... Transcutaneous monitoring of oxygen and carbon ... now used in a number of different ... surgery, hyperbaric medicine and orthopedic surgery. TcpO2 ... three sites to provide a good picture. ...
Spherical Burr for FR030R, 5 mm....
Hough Hough Burr-Saw for Crurotomy, 1 mm, ISO-No. 010....
Medicine Products: